These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1689227)

  • 1. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis.
    Mix E; Olsson T; Correale J; Baig S; Kostulas V; Olsson O; Link H
    Clin Exp Immunol; 1990 Jan; 79(1):21-7. PubMed ID: 1689227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional features of CD5+ B lymphocytes in rheumatoid arthritis.
    Plater-Zyberk C; Maini RN
    Scand J Rheumatol Suppl; 1988; 75():76-83. PubMed ID: 2467354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5+ B cells and CD4-8-T cells in neuroimmunological diseases.
    Correale J; Mix E; Olsson T; Kostulas V; Fredrikson S; Höjeberg B; Link H
    J Neuroimmunol; 1991 May; 32(2):123-32. PubMed ID: 1826505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of CD5+ B lymphocytes in the peripheral blood of patients with myasthenia gravis.
    Ragheb S; Lisak RP
    Neurology; 1990 Jul; 40(7):1120-4. PubMed ID: 1694020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of CD5 - B cells in multiple sclerosis correlates with CD80 (B7-1) expression.
    Sellebjerg F; Jensen J; Jensen CV; Wiik A
    Scand J Immunol; 2002 Jul; 56(1):101-7. PubMed ID: 12100477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune surveillance in multiple sclerosis patients treated with natalizumab.
    Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
    Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients.
    MacKenzie MR; Paglieroni T; Caggiano V
    Am J Hematol; 1991 Jul; 37(3):163-6. PubMed ID: 1713410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocyte subsets in Hashimoto's thyroiditis.
    Suranyi P; Szegedi G; Damjanovich S; Juhasz F; Stenszky V; Farid NR
    Immunol Lett; 1989 Aug; 22(2):147-50. PubMed ID: 2476382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal B cell compartment in chronic lymphatic leukemia.
    Pluta A; Górski A; Nowaczyk M; Modlińska M
    Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals.
    Yi Q; Ahlberg R; Pirskanen R; Lefvert AK
    Neurology; 1992 May; 42(5):1081-4. PubMed ID: 1374547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased numbers of CD5+ B lymphocytes in schizophrenic patients.
    McAllister CG; Rapaport MH; Pickar D; Podruchny TA; Christison G; Alphs LD; Paul SM
    Arch Gen Psychiatry; 1989 Oct; 46(10):890-4. PubMed ID: 2478093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD5 on B lymphocytes correlates with disease activity in patients with multiple sclerosis.
    Seidi OA; Semra YK; Sharief MK
    J Neuroimmunol; 2002 Dec; 133(1-2):205-10. PubMed ID: 12446024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.
    Corcione A; Casazza S; Ferretti E; Giunti D; Zappia E; Pistorio A; Gambini C; Mancardi GL; Uccelli A; Pistoia V
    Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11064-9. PubMed ID: 15263096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
    Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
    Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased CD5-positive B lymphocytes in type I diabetes.
    Muñoz A; Gallart T; Viñas O; Gomis R
    Clin Exp Immunol; 1991 Feb; 83(2):304-8. PubMed ID: 1704297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease.
    Svenningsson A; Dotevall L; Stemme S; Andersen O
    J Neuroimmunol; 1997 May; 75(1-2):59-68. PubMed ID: 9143238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.
    Eggers EL; Michel BA; Wu H; Wang SZ; Bevan CJ; Abounasr A; Pierson NS; Bischof A; Kazer M; Leitner E; Greenfield AL; Demuth S; Wilson MR; Henry RG; Cree BA; Hauser SL; von Büdingen HC
    JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
    Becker H; Weber C; Storch S; Federlin K
    Clin Immunol Immunopathol; 1990 Aug; 56(2):219-25. PubMed ID: 1696188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.